La Jolla Pharmaceutical Company (NASDAQ:LJPC) - Page 2

analysis

Top Analyst Upgrades and Downgrades: CenturyLink, Gold Fields, Papa John’s, Priceline, SolarCity, Tesla, Unisys and More

Despite two days of pre-Brexit gains, stocks were indicated marginally higher again on Wednesday morning. While the reason seems to be different each and every time, investors have found the ...
Read Full Story »
automatic inspection machine

6 Biotech and Pharma Stocks Analysts Want You to Buy Now

The end of 2015 and the start of 2016 have been hard on biotech, and in some cases have been hard for Big Pharma. It turns out that there is ...
Read Full Story »
buy sell

Top Analyst Upgrades and Downgrades: Apple, Freeport-McMoRan, Kinross Gold, Pfizer, Plains All American, Salesforce, Tesla, Yelp and More

Stocks were getting pounded on Tuesday. The selling pressure seems to not have an end in 2016, even after investors successfully bought every dip for over four years. It still ...
Read Full Story »
Money, US, $100 bills

La Jolla Gears Up for Secondary Offering

La Jolla Pharmaceuticals Co. (NASDAQ: LJPC) has been on a tear over the past year. Now it is looking to capitalize on its increased price and raise more capital. The ...
Read Full Story »
buy sell

Insider Buying Surges During Sell-Off: Sprint, Sears, SolarCity and More

If there was ever a week where we saw disproportionate numbers in insider activity, it was this week. Insiders from every sector took advantage of the gigantic wash-out last Monday ...
Read Full Story »
145922793

Can La Jolla Pharma Shares Really Double?

Health care is still going strong in April, and biotech and emerging pharmaceutical stocks still have huge gains so far in 2015. La Jolla Pharmaceutical Co. (NASDAQ: LJPC) has seen ...
Read Full Story »
Wall Street

Despite Huge Rally, High-Profile Insiders Still Buying Stocks

With one of the largest weekly rallies in almost three years printed and in the books, one would expect that insiders looking to add to their positions would wait for ...
Read Full Story »
ten dollar bills

11 Analyst Stock Picks Under $10 With Massive Upside Potential

Stocks seem to be migrating from a tired bull market phase into a phase of volatility. It is also a phase where broad-based upside might not be an automatic assumption ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, AEP, Chubb, Chevron, Halcon, Noble and More

Stocks took it on the chin last week, but the markets are indicated firm on Monday morning. Investors are still looking for upside from stocks, particularly among stocks that sold ...
Read Full Story »
biotech

La Jolla Pharmaceutical Shares Surge on Positive Trial Results

La Jolla Pharmaceutical Co. (NASDAQ: LJPC) shares surged after the micro-cap biotech said late Monday that its study for a chronic kidney disease treatment showed a statistically significant improvement. The ...
Read Full Story »
Burning Money Pic

Many Biotechs Barely On Life Support (BPAX, CEGE, EPIX, IDMI, LJPC, NRGN, NFLD, TPTX)

We have run a watch list of companies under their own strategic review, and the number of biotech (or grouped with biotech) stocks under this description is just staggering.   We ...
Read Full Story »
Money_stack_pic_5

La Jolla Gets More Hope (LJPC, BMRN)

La Jolla Pharmaceutical Company (NASDAQ: LJPC) has been more than just a troubled biotech.  It has even been considered an at-risk entity by some traders after it had been down ...
Read Full Story »

Biotech Business Daily (BIIB, GSK, ILMN, IVGN, LJPC, SIRT, STEM)

Biogen Idec (NASDAQ: BIIB) is sliding marginally despite reported earnings today that showed a 23% increase in earnings riding on sales growth on Avonex and Rituxan. The earnings beat estimates ...
Read Full Story »